Blar i University of Bergen Library på tidsskrift "Neurogastroenterology and Motility"
Viser treff 1-6 av 6
-
Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
(Journal article; Peer reviewed, 2020)Background Short‐chain fatty acids (SCFAs) may play a role in the pathophysiology of irritable bowel syndrome (IBS). This study analyzed fecal SCFAs after performing fecal microbiota transplantation (FMT) in the IBS ... -
Current status of fecal microbiota transplantation for irritable bowel syndrome
(Journal article; Peer reviewed, 2021)Background Irritable bowel syndrome (IBS) is a common gastrointestinal functional disorder. Although IBS is a benign condition, it reduces the quality of life considerably. While there is currently no effective treatment ... -
Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome
(Journal article; Peer reviewed, 2023)Background A previous study that introduced a Fecal microbiota transplantation (FMT) protocol with a high efficacy applied a combination of favorable factors. Aims The present study aimed to evaluate some of these ... -
Gastric function in diabetic gastroparesis assessed by ultrasound and scintigraphy
(Journal article; Peer reviewed, 2021)Background: Gastroparesis is a severe diabetes complication characterized by delayed gastric emptying. We examined patients with symptoms of diabetic gastroparesis using gastric emptying scintigraphy and ultrasound drink ... -
Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation
(Journal article; Peer reviewed, 2022)Background Fecal microbiota transplantation (FMT) interventions have recently been advocated to not succeed in every irritable bowel syndrome (IBS) patient, since the outcome of FMT varies with the IBS subset. This study ... -
Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome
(Journal article; Peer reviewed, 2021)Background We recently found fecal microbiota transplantation (FMT) in irritable bowel syndrome (IBS) patients to be an effective and safe treatment after 3 months. The present follow-up study investigated the efficacy ...